stars 1 stars 2 stars 3

InSimili s.r.l. is a private biotechnology company that aims to bring to the market a patented technology, which will revolutionize the drug selection process. Our product can recreate the microenvironment of pathological and physiological conditions in standard cell culture containers. Our solution bridges the gap between patients and in vitro studies, enabling a better evaluation of the real efficacy of innovative treatments. By selecting better drug candidates early, pharmaceutical companies can minimize the risk of failures in the clinical phases, saving time and billions of dollars.

InSimili Questions

Stefania Rapino is the CTO of InSimili.

2 people are employed at InSimili.

Top InSimili Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users